Class IITerminatedD-1838-2019
Drug recall · July 31, 2019
Keppra (levetiracetam) 1000 mg tablets recall
Why: Failed Dissolution Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Keppra (levetiracetam) 1000 mg tablets, 60 tablets per bottle, Rx only, Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-597-66.
- Lots / codes
Lot: 908946 Exp. 02/2022
- Quantity
- 2088 bottles
- Company
- Ucb, Inc, Smyrna, GA
- Distribution
- TN
- Initiated
- July 18, 2019 · Voluntary: Firm initiated
- Classified
- August 21, 2019
- Reported
- July 31, 2019
- Ended
- January 24, 2020
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Keppra
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.